Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1994Journal of Clinical Oncology

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.

View Full Paper
Ask AI
Bookmark
Share

Authors

HBHoward H. BaileyUniversity of Wisconsin–MadisonRMRíona MulcahyUniversity of MichiganKTK D TutschUniversity of Wisconsin–Madison

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bailey et al. (1994) studied this question.

synapsesocial.com/papers/69d80979fc5937d393ae2adchttps://doi.org/10.1200/jco.1994.12.1.194
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).1979 · 1,697 citations
  2. 2Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects1988 · 225 citations